Loading market dashboard
Zomedica Corp.
ZOMHealthcareAMEXUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
Zomedica Corp. (ZOMDF) Q1 2026 Earnings Call Transcript
Collaboration with USEA for Zomedica's PulseVet® shock wave system will increase brand awareness among Eventing enthusiasts. ANN ARBOR, MI / ACCESS Newswire / May 20, 2026 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic products for equine and companion animals, today announced the renewal of its sponsorship agreement with the United States Eventing Association (USEA).
May session to review Q1 2026 financial results alongside an investor-focused look at the companion animal market for veterinary technology and Zomedica's integrated small-animal portfolio, spanning in-clinic diagnostics, therapeutic solutions, and procedural care tools driving recurring revenue across companion animal veterinary practices ANN ARBOR, MI / ACCESS Newswire / May 14, 2026 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative diagnostic and therapeutic devices for equine and companion animals, today announced the next installment of its investor webinar series, "Fifth Friday at Four," scheduled for Friday, May 29, 2026 at 4:00 p.m. Eastern Time.
Zomedica surpasses $8 million in first quarter revenue for the first time and delivers record year-over-year revenue for 21st straight quarter. ANN ARBOR, MI / ACCESS Newswire / May 6, 2026 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic products for equine and companion animals, today reported consolidated financial results for the first quarter ended March 31, 2026.
Zomedica Corp. (ZOMDF) Discusses Manufacturing Strategy and Quality Operations for Veterinary Diagnostics and Therapeutics Transcript
April session to take investors inside Zomedica's manufacturing operations - showcasing quality systems, automation, and teams driving scalable product fulfillment providing substantial margins ANN ARBOR, MI / ACCESS Newswire / April 16, 2026 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative diagnostic and therapeutic solutions for equine and companion animals, today announced the next installment of its "Fourth Friday at Four" investor webinar series, scheduled for Friday, April 24, 2026 at 4:00 p.m. Eastern Time.
Zomedica Corp. (ZOMDF) Discusses the Equine Veterinary Market Opportunity Transcript
Zomedica surpasses $10 million in quarterly revenue for the first time and delivers record year-over-year revenue for 20th straight quarter. ANN ARBOR, MI / ACCESS Newswire / March 16, 2026 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today reported consolidated financial results for the fourth quarter and year ended December 31, 2025.
Webinar will include a review of full-year 2025 and fourth quarter 2025 financial results, a deep dive into the equine veterinary market and Zomedica's equine-focused product portfolio, along with a live Q&A session. ANN ARBOR, MI / ACCESS Newswire / March 10, 2026 / Zomedica Corp. (OTCQB:ZOMDF), a veterinary health company offering advanced diagnostic and therapeutic solutions for equine and companion animals, today announced that its upcoming "Fourth Friday at Four" investor webinar will include a review of its fourth quarter and full year 2025 financial results along with a deep dive into the equine veterinary marketplace, highlighting the size of the market opportunity and the products and experts supporting Zomedica's growing presence in the segment.
